Nerenz et al developed an index to identify patients receiving chemotherapy who were likely to develop anticipatory nausea. This is based on findings following the first administration of chemotherapy. The index can help identify patients who may benefit from interventions to reduce the experience of nausea. The authors are from the University of Wisconsin and the Middleton Memorial VA Hospital in Madison, Wisconsin.
